Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control
1997
Neurovascular Damage in Experimental Allergic Encephalomyelitis
publication
Evidence: moderate
Author Information
Author(s): C. Bolton
Primary Institution: University of Bath
Hypothesis
What are the mechanisms and consequences of EAE-induced immune-mediated insults on the blood-brain barrier?
Conclusion
The study suggests that pharmacological interventions can help control blood-brain barrier breakdown in demyelinating diseases.
Supporting Evidence
- The blood-brain barrier is crucial for maintaining brain health and is disrupted in diseases like EAE.
- Pharmacological agents like glucocorticoids can help restore blood-brain barrier integrity.
- Experimental models show that various inflammatory mediators contribute to blood-brain barrier breakdown.
Takeaway
This study looks at how a disease called EAE affects the blood-brain barrier, which is like a protective wall for the brain, and how medicines might help fix it.
Methodology
The review discusses various mechanisms and therapeutic approaches related to blood-brain barrier integrity in EAE.
Limitations
The study primarily focuses on animal models, which may not fully represent human conditions.
Want to read the original?
Access the complete publication on the publisher's website